New MRI Method Measures Brain Layer Thinning in Down Syndrome Mice
This could lead to earlier detection of brain changes in Down syndrome and Alzheimer's.
Scientists introduce a framework to extract the Purkinje layer within the cerebellar grey matter, enabling estimation of the thickness of the cerebellar grey matter, the granular layer, and the molecular layer from gadolinium-enhanced ex vivo mouse brain MRI. The article notes that cerebellar grey matter morphology—its volume or thickness—is commonly used as a surrogate imaging biomarker for neurodegenerative diseases such as Alzheimer's disease or Down's syndrome, while most studies on grey matter thickness estimation have focused on the cortex and little attention has been drawn to the morphology of the cerebellum.
Using ex vivo high-resolution MRI, it is now possible to visualise the different cell layers in the mouse cerebellum. In application to a mouse model of Down's syndrome, the work found reduced cortical and layer thicknesses in the transchromosomic group.
- A new MRI method can measure the thickness of brain layers in mice, focusing on the cerebellum.
- In a Down syndrome mouse model, researchers found reduced thickness in several brain layers.
- This technique could help track neurodegenerative diseases and test treatments earlier.
Why It Matters
Could lead to earlier detection and better treatments for brain disorders like Alzheimer's and Down syndrome.